Ricerca

Pubblicazioni IRIS

• A NSC‐34 cell line‐derived spheroid model: potential and challenges for in vitro evaluation of neurodegeneration
  Anno: 2024
• Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+ breast cancer cells
  Anno: 2023
• Lipid Metabolism Reprogramming and Trastuzumab Resistance in Breast Cancer Cell Lines Overexpressing the ERBB2 Membrane Receptor
  Anno: 2023
• Responses of Mytilus galloprovincialis to challenge with environmental isolates of the potential emerging pathogen Malaciobacter marinus
  Anno: 2022
• Trastuzumab Modulates the Protein Cargo of Extracellular Vesicles Released by ERBB2+ Breast Cancer Cells
  Anno: 2021